Search Results - "Storti, Gabriella"
-
1
Vitamin C effect on mitoxantrone-induced cytotoxicity in human breast cancer cell lines
Published in PloS one (22-12-2014)“…In recent years the use of natural dietary antioxidants to minimize the cytotoxicity and the damage induced in normal tissues by antitumor agents is gaining…”
Get full text
Journal Article -
2
Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey)
Published in Bone marrow transplantation (Basingstoke) (01-09-2021)“…The Transplant Centers belonging to Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO) conducted a survey with the aim of evaluating the effect of…”
Get full text
Journal Article -
3
Letermovir Prophylaxis for Cytomegalovirus Infection in Allogeneic Stem Cell Transplantation: A Real-World Experience
Published in Frontiers in oncology (06-09-2021)“…Despite effective treatments, cytomegalovirus (CMV) continues to have a significant impact on morbidity and mortality in allogeneic stem cell transplant…”
Get full text
Journal Article -
4
Intestinal and Extraintestinal Findings of Graft-versus-Host Disease on CT: A Case Series with Radiological and Histopathological Correlations
Published in Biomedicines (08-07-2024)“…Graft-versus-host disease (GVHD) is an expected and relatively common complication after allogeneic hematopoietic stem cell transplantation. It may affect…”
Get full text
Journal Article -
5
Limited efficacy of 3 + 7 plus gemtuzumab ozogamycin in newly diagnosed fit intermediate genetic risk acute myeloid leukemia patients
Published in Cancer reports (01-04-2024)“…Background Gemtuzumab‐ozogamycin (GO) is approved in combination with high‐dose chemotherapy for treatment‐naïve low‐ and intermediate‐risk acute myeloid…”
Get full text
Journal Article -
6
Post-Transplant Cyclophosphamide versus Anti-Thymocyte Globulin in Patients with Hematological Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Haploidentical and Matched Unrelated Donors: A Real-Life Experience
Published in Hematology reports (17-04-2024)“…Post-transplant cyclophosphamide (PTCY) is widely used as graft versus host disease (GvHD) prophylaxis in allogeneic hematopoietic stem cell transplant (HSCT)…”
Get full text
Journal Article -
7
-
8
Synergistic Antitumor Effect of Doxorubicin and Tacrolimus (FK506) on Hepatocellular Carcinoma Cell Lines
Published in TheScientificWorld (01-01-2014)“…Hepatocellular carcinoma is the fifth most common cancer worldwide and shows a complex clinical course, poor response to pharmacological treatment, and a…”
Get full text
Journal Article -
9
GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia
Published in Blood (19-09-2019)“…We designed a trial in which postremission therapy of young patients with de novo acute myeloid leukemia (AML) was decided combining cytogenetics/genetics and…”
Get full text
Journal Article -
10
Combining doxorubicin with a phenolic extract from flaxseed oil: Evaluation of the effect on two breast cancer cell lines
Published in International journal of oncology (01-02-2017)“…Breast cancer is one of the most frequently diagnosed forms of cancer and different treatments are used to block its progression. However, it still represents…”
Get full text
Journal Article -
11
Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group
Published in Bone marrow transplantation (Basingstoke) (01-09-2021)“…The Transplant Centers belonging to Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO) conducted a survey with the aim of evaluating the effect of…”
Get full text
Journal Article -
12
Results of the 6-Year Follow-up of the Gimema AML1310 Trial: A Risk-Adapted, MRD-Directed Therapy for Young Adults with Newly Diagnosed Acute Myeloid Leukemia
Published in Blood (23-11-2021)“…Background: In the AML1310 trial, we applied a comprehensive AML risk assessment, based on the integration of cytogenetic/genetic data and measurable residual…”
Get full text
Journal Article -
13
Validation of ELN2017 Risk Stratification in a Post-Hoc Analysis of the Prospective Biomarker-Based Gimema AML1310 Protocol
Published in Blood (05-11-2020)“…Background: In the 2017 version of the ELN recommendations (ELN2017), a comprehensive evaluation of karyotype and mutational status of specific genes (e.g…”
Get full text
Journal Article -
14
Suspected chromosomally integrated human herpes virus 6 in hematopoietic stem cell transplantation
Published in Microbiologia Medica (31-03-2016)“…Background and aims: We report a case of a 27-year-old male affected by acute myeloid leukaemia MLL-PTD positive. After autologous stem cell transplantation,…”
Get full text
Journal Article -
15
Fatigue in newly diagnosed acute myeloid leukaemia: general population comparison and predictive factors
Published in BMJ supportive & palliative care (01-11-2023)“…This study compared the burden of fatigue between treatment-naïve patients with newly diagnosed acute myeloid leukaemia (AML) and the general population and…”
Get more information
Journal Article -
16
Anti-Inflammatory Effects of a Methanol Extract from the Marine Sponge Geodia cydonium on the Human Breast Cancer MCF-7 Cell Line
Published in Mediators of Inflammation (01-01-2015)“…Many research groups are working to find new possible anti-inflammatory molecules, and marine sponges represent a rich source of biologically active compounds…”
Get full text
Journal Article -
17
Risk-adapted MRD-directed therapy for young adults with acute myeloid leukemia: 6-year update of the GIMEMA AML1310 trial
Published in Blood advances (27-08-2024)Get full text
Journal Article -
18
ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol
Published in Blood advances (26-04-2022)“…The 2017 version of the European LeukemiaNet (ELN) recommendations, by integrating cytogenetics and mutational status of specific genes, divides patients with…”
Get full text
Journal Article -
19
Comparison of quantitative HCMV DNAemia in whole blood and leukocytes, and Real-Time PCR in a BMT patient
Published in Microbiologia Medica (31-03-2012)“…Background. HCMV is the most opportunistic viral agent in the transplantation of bone marrow and solid organ. Early therapy based on the detection of HCMV pp65…”
Get full text
Journal Article